3 CYCLES OF CHEMOTHERAPY FOLLOWED BY PRIMARY CYTOREDUCTIVE SURGERY FOR UNRESECTABLE OVARIAN-CANCER

被引:1
|
作者
GUIDOZZI, F
SONNENDECKER, EWW
机构
关键词
D O I
10.1016/0090-8258(91)90043-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Definitive primary cytoreductive surgery was achieved at second laparotomy after three cycles of combination chemotherapy (cisplatin and cyclophosphamide) in three patients who presented with unresectable disease at our Ovarian Tumor Unit. The ovarian cancer was inoperable at the first laparotomy and no surgical procedure was performed other than biopsy of malignant tumor to confirm the diagnosis. Following interventional surgical cytoreduction the patients were given a further six courses of combination chemotherapy and then maintained for a further six cycles on oral chlorambucil. Two patients are disease free at 17 and 21 months, respectively, while the other patient has cytological evidence of malignancy but no other clinically detectable tumor deposits at 27 months. © 1991.
引用
收藏
页码:313 / 316
页数:4
相关论文
共 50 条
  • [31] Primary Cytoreductive Surgery Versus Neoadjuvant Chemotherapy Followed by Surgery in Patients with Advanced Primary Epithelial Ovarian Cancer in Low Resources Setting: A Randomized Clinical Trial
    Abutaleb, Hisham
    Hussien, Ali
    Khalaf, Mohamed
    Badary, Dalia M.
    Ismail, Alaa M.
    Hassanein, Sara
    Algizawy, Samy
    Moustafa, S. A. M.
    Farghaly, Rabab Mohmed Mumdouh
    Abdel-Kawi, A. F.
    JOURNAL OF OBSTETRICS AND GYNECOLOGY OF INDIA, 2024,
  • [32] Neoadjuvant chemotherapy and cytoreductive surgery in epithelial ovarian cancer
    Siriwan Tangjitgamol
    Jitti Hanprasertpong
    Marta Cubelli
    Claudio Zamagni
    World Journal of Obstetrics and Gynecology, 2013, (04) : 153 - 166
  • [33] Primary surgery or neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer
    Vergote, Ignace
    Amant, Frederic
    Kristensen, Gunnar
    Ehlen, Tom
    Reed, Nick S.
    Casado, Antonio
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S88 - S92
  • [34] Neoadjuvant chemotherapy followed by surgery and adjuvant chemotherapy in patients with primarily unresectable, advanced-stage ovarian cancer
    Mazzeo, F
    Berlière, M
    Kerger, J
    Squifflet, J
    Duck, L
    D'Hondt, V
    Humblet, Y
    Donnez, J
    Machiels, JP
    GYNECOLOGIC ONCOLOGY, 2003, 90 (01) : 163 - 169
  • [35] Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in ovarian cancer
    Schmalfeldt, Barbara
    CHIRURGIE, 2022, 93 (12): : 1144 - 1151
  • [36] Cytoreductive surgery and perioperative intraperitoneal chemotherapy for the treatment of advanced primary and recurrent ovarian cancer
    Sugarbaker, Paul H.
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2009, 21 (01) : 15 - 24
  • [37] RESECTION OF DIAPHRAGMATIC PERITONEUM AND MUSCLE - ROLE IN CYTOREDUCTIVE SURGERY FOR OVARIAN-CANCER
    MONTZ, FJ
    SCHLAERTH, JB
    BEREK, JS
    GYNECOLOGIC ONCOLOGY, 1989, 35 (03) : 338 - 340
  • [38] Correct timing of cytoreductive surgery and chemotherapy in ovarian cancer: Neoadjuvant chemotherapy
    Pignata, S
    Tambaro, R
    TUMORI JOURNAL, 2003, : S37 - S37
  • [39] PRIMARY SURGERY IN OVARIAN-CANCER - CURRENT OPINIONS
    HOGBERG, T
    ANNALS OF MEDICINE, 1995, 27 (01) : 95 - 100
  • [40] CHEMOTHERAPY FOR OVARIAN-CANCER
    KAYE, SB
    EUROPEAN JOURNAL OF CANCER, 1993, 29A (04) : 632 - 635